356
Views
14
CrossRef citations to date
0
Altmetric
Original Article

Evaluation of different RGD ligand densities in the development of cell-based drug delivery systems

, , , &
Pages 806-812 | Received 23 Dec 2014, Accepted 14 Feb 2015, Published online: 27 Mar 2015
 

Abstract

Background: The inclusion of the tripeptide Arg-Gly-Asp (RGD) in otherwise inert biomaterials employed for cell encapsulation has been observed to be an effective strategy to provide the immobilized cells with a more suitable microenvironment.

Purpose: The objective of this study was to determine the impact of different RGD densities on the behavior of baby hamster kidney (BHK) fibroblasts able to secrete vascular endothelial growth factor (VEGF) encapsulated in alginate microcapsules.

Methods: Alginate was modified by varying the concentration of RGD peptides in the coupling reaction. After obtaining four different types of alginate, cells were encapsulated in alginate-poly-l-lysine-alginate (APA) microcapsules.

Results and discussion: The results obtained after viability, cell proliferation and VEGF secretion assays showed that the inclusion of RGD in alginate enhances the functionality of immobilized cells, obtaining the highest values with the intermediate RGD density.

Conclusion: These results put in evidence that alginate modification influences the behavior of immobilized cells but even more that the employed density of the tripeptide is of crucial importance, obtaining in some cases even excessive activity of the encapsulated cells.

Acknowledgements

Authors would like to thank Ricardo Andrade for technical help with confocal microscopy.

Declaration of interest

The authors gratefully acknowledge the support to research cell microencapsulation from the “Ministerio de Ciencia e Innovación”, University of the Basque Country UPV/EHU (UFI11/32) and FEDER funds (SAF2008-03157). A. Garate thanks the “Gobierno Vasco (Departamento de Educación, Universidades e Investigación)” for the PhD fellowship.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.